BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21799303)

  • 1. Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells.
    Cheng G; Lopez M; Zielonka J; Hauser AD; Joseph J; McAllister D; Rowe JJ; Sugg SL; Williams CL; Kalyanaraman B
    Cancer Biol Ther; 2011 Oct; 12(8):707-17. PubMed ID: 21799303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
    Cheng G; Zielonka J; McAllister D; Hardy M; Ouari O; Joseph J; Dwinell MB; Kalyanaraman B
    Cancer Lett; 2015 Aug; 365(1):96-106. PubMed ID: 26004344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells.
    Taylor-Harding B; Orsulic S; Karlan BY; Li AJ
    Gynecol Oncol; 2010 Dec; 119(3):549-56. PubMed ID: 20837358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways.
    Kotamraju S; Williams CL; Kalyanaraman B
    Cancer Res; 2007 Aug; 67(15):7386-94. PubMed ID: 17671209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells.
    Goard CA; Chan-Seng-Yue M; Mullen PJ; Quiroga AD; Wasylishen AR; Clendening JW; Sendorek DH; Haider S; Lehner R; Boutros PC; Penn LZ
    Breast Cancer Res Treat; 2014 Jan; 143(2):301-12. PubMed ID: 24337703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria-targeted nitroxide, Mito-CP, suppresses medullary thyroid carcinoma cell survival in vitro and in vivo.
    Starenki D; Park JI
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1529-40. PubMed ID: 23509102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress.
    Sánchez CA; Rodríguez E; Varela E; Zapata E; Páez A; Massó FA; Montaño LF; Lóopez-Marure R
    Cancer Invest; 2008 Aug; 26(7):698-707. PubMed ID: 18608208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin-induced inhibition of breast cancer proliferation and invasion involves attenuation of iron transport: intermediacy of nitric oxide and antioxidant defence mechanisms.
    Kanugula AK; Gollavilli PN; Vasamsetti SB; Karnewar S; Gopoju R; Ummanni R; Kotamraju S
    FEBS J; 2014 Aug; 281(16):3719-38. PubMed ID: 24964743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death.
    Cheng G; Zielonka J; Dranka BP; McAllister D; Mackinnon AC; Joseph J; Kalyanaraman B
    Cancer Res; 2012 May; 72(10):2634-44. PubMed ID: 22431711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytostatic Effect of a Novel Mitochondria-Targeted Pyrroline Nitroxide in Human Breast Cancer Lines.
    Andreidesz K; Szabo A; Kovacs D; Koszegi B; Bagone Vantus V; Vamos E; Isbera M; Kalai T; Bognar Z; Kovacs K; Gallyas F
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvastatin enhancement of trastuzumab and classical cytotoxic agents in defined breast cancer cell lines in vitro.
    Budman DR; Tai J; Calabro A
    Breast Cancer Res Treat; 2007 Jul; 104(1):93-101. PubMed ID: 17004104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoledronic acid (Zometa) enhances the cytotoxic effect of gemcitabine and fluvastatin: in vitro isobologram studies with conventional and nonconventional cytotoxic agents.
    Budman DR; Calabro A
    Oncology; 2006; 70(2):147-53. PubMed ID: 16645328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide.
    Dhanasekaran A; Kotamraju S; Karunakaran C; Kalivendi SV; Thomas S; Joseph J; Kalyanaraman B
    Free Radic Biol Med; 2005 Sep; 39(5):567-83. PubMed ID: 16085176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay.
    Knight LA; Kurbacher CM; Glaysher S; Fernando A; Reichelt R; Dexel S; Reinhold U; Cree IA
    BMC Cancer; 2009 Jan; 9():38. PubMed ID: 19175937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidative potential of fluvastatin via the inhibition of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity.
    Bandoh T; Sato EF; Mitani H; Nakashima A; Hoshi K; Inoue M
    Biol Pharm Bull; 2003 Jun; 26(6):818-22. PubMed ID: 12808293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mitochondrially targeted carboxy proxyl nitroxide on Akt-mediated survival in Daudi cells: Significance of a dual mode of action.
    Variar G; Pant T; Singh A; Ravichandran A; Swami S; Kalyanaraman B; Dhanasekaran A
    PLoS One; 2017; 12(4):e0174546. PubMed ID: 28426671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma.
    Mercurio S; Padovani L; Colin C; Carré M; Tchoghandjian A; Scavarda D; Lambert S; Baeza-Kallee N; Fernandez C; Chappé C; André N; Figarella-Branger D
    Acta Neuropathol Commun; 2013 May; 1():17. PubMed ID: 24252689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvastatin attenuates IGF-1-induced ERK1/2 activation and cell proliferation by mevalonic acid depletion in human mesangial cells.
    Shibata T; Tamura M; Kabashima N; Serino R; Tokunaga M; Matsumoto M; Miyamoto T; Miyazaki M; Furuno Y; Takeuchi M; Abe H; Okazaki M; Otsuji Y
    Life Sci; 2009 May; 84(21-22):725-31. PubMed ID: 19254730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells.
    Gao P; Wu X; Shui H; Jia R
    J Nephrol; 2013; 26(2):289-96. PubMed ID: 22641573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line.
    Niwa S; Totsuka T; Hayashi S
    Int J Immunopharmacol; 1996 Nov; 18(11):669-75. PubMed ID: 9089010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.